Does sumatriptan cross the blood-brain barrier in animals and man? - Wikidata - wikimedia - TriplyDB

Does sumatriptan cross the blood-brain barrier in animals and man?

Does sumatriptan cross the blood-brain barrier in animals and man?

http://www.wikidata.org/entity/Q36260908

about

Serotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered.Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache Migraine attacks the Basal Ganglia.Female migraineurs show lack of insular thinning with age Effects of Voluntary Locomotion and Calcitonin Gene-Related Peptide on the Dynamics of Single Dural Vessels in Awake Mice.Prenatal Triptan Exposure and Internalising and Externalising Behaviour Problems in 3-Year-Old Children: Results from the Norwegian Mother and Child Cohort Study.Common hippocampal structural and functional changes in migraine 5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?Antidromic vasodilatation and the migraine mechanism.Sumatriptan succinate : pharmacokinetics of different formulations in clinical practice.Serotonergic mechanisms in the migraine brain - a systematic review.Sumatriptan inhibition of N-type calcium channel mediated signaling in dural CGRP terminal fibres.Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity.Evidence for a vascular factor in migraine.Side effects associated with current and prospective antimigraine pharmacotherapies.Hydrophilic anti-migraine triptans are substrates for OATP1A2, a transporter expressed at human blood-brain barrier.Concentration effects of sumatriptan on the properties of model membranes by molecular dynamics simulations.Triptans attenuate circadian responses to light.Region-specific disruption of the blood-brain barrier following repeated inflammatory dural stimulation in a rat model of chronic trigeminal allodynia.The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteers

P2860

Q30786129-3E15B12F-ABB0-4FAA-BDD8-2BE12208B28A Q33921986-3FEDE28E-55DF-40A3-81BF-2935CA236FAA Q35338284-F1B3A06E-646B-408D-B2B2-93F6C3F1F1B4 Q35761460-EE687490-3EB7-4BB5-807F-F0860DD4A8F9 Q35934682-6DF2DD30-B507-4C73-99C3-CF570CEC71F2 Q36567997-31B29B1F-38D0-4D32-A3A4-D3945046D659 Q37013278-B446F248-5AC9-47F0-917D-42817E1E79DD Q37739587-460D0810-7C69-4A21-99F3-1397A534CFAF Q37971447-DFC8C914-33CE-4174-8850-89421A3705C5 Q38046616-6426D165-C251-4DD0-B7E0-F07FEF7E4790 Q38788172-22AAB386-36ED-44C6-B8A6-092C31CC0374 Q42073244-CE2DAE04-EBF2-4336-A40B-EC07881E1CB8 Q44162350-12C7C02F-6B15-4B10-8ED4-6A3CBA65EE01 Q45024230-8D37D607-F1A1-4D78-92DE-959624DB03FF Q47309054-6685B64E-1F9C-47DA-B244-BDB9B21EC335 Q48564258-8A5C7B79-B7DE-4E3E-80ED-BDD31B580EF4 Q48967820-EFD2032A-F8C5-49E5-9C1D-09D965B6FE2F Q51741766-91B1E087-98C1-48A6-B017-7FF6EAB80C3D Q52096863-537BD51D-E974-4EF9-A09F-6BF2F3031E1A Q57023896-0E9D6C14-1DD9-45F0-8710-06549B00F478

P2860

Does sumatriptan cross the blood-brain barrier in animals and man?

http://www.wikidata.org/entity/Q36260908

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Does sumatriptan cross the blood-brain barrier in animals and man?

@ast

Does sumatriptan cross the blood-brain barrier in animals and man?

@en

type

label

Does sumatriptan cross the blood-brain barrier in animals and man?

@ast

Does sumatriptan cross the blood-brain barrier in animals and man?

@en

prefLabel

Does sumatriptan cross the blood-brain barrier in animals and man?

@ast

Does sumatriptan cross the blood-brain barrier in animals and man?

@en

P1433

Q36260908-2DCB6181-4A20-44FC-B206-A8C3F0DCA687

P1476

Q36260908-D6515CEE-1DCB-4FD9-9FB0-DFF36E709421

P2860

Q36260908-013AE0EE-0766-450F-B19F-EAFF015B9A93

Q36260908-02D5A571-F63B-4F12-850B-8B20516F5672

Q36260908-091A1FD3-8CBF-4A48-8794-2E71A384F92A

Q36260908-09A840E0-D34B-4258-A61E-6D805693A9CA

Q36260908-0A4341D1-3AAD-4A3F-8338-85CEBCBC66B8

Q36260908-0DE83A54-7A87-4007-9949-5C65FEA2AAE2

Q36260908-10349699-B575-4A2B-85D7-7650812E2E81

Q36260908-10CEEDE8-D449-4FC5-846A-0E12E2C89512

Q36260908-13167C53-2632-4FF5-832D-F764ADBDFA9A

Q36260908-142D115F-780C-4741-A3ED-902F4F4E6F39

P2888

Q36260908-B23B625D-4118-4E68-9F90-8C9F1FF8BEF1

P304

Q36260908-308E2FBA-DB04-4508-A666-7487EF4FDCEB

P31

Q36260908-81162257-C0A4-40E0-A45F-8D741C250277

Q36260908-C4412EAA-0B7F-4C15-96A4-2A6ECC25CF42

P356

Q36260908-15E4BAC5-E50B-4171-B41C-CB852FFCB05A

P433

Q36260908-64B139F0-7C60-4C48-B02B-9E5259D6D2BD

P478

Q36260908-CDDC6242-AB60-4067-A63B-9A912B6CB12C

P50

Q36260908-63A9469E-3714-4E31-8E21-2210AAE9930C

P577

Q36260908-760272DF-832C-4CAC-803D-5871F7126E6B

Q36260908-B5276A38-EC11-4380-81E9-DE2519878F26

P5875

Q36260908-0DE4B61F-66F2-4C2F-BB36-8AB1C52A3DA6

P698

Q36260908-CCB71B1C-B3DF-4A06-AAFA-3767F6918680

P921

Q36260908-3C4B4661-9F80-43AD-B59B-5FD90160ED70

Q36260908-7B1E5CB7-062B-4F3A-9027-54FE02618927

Q36260908-92CB06A3-6FA8-4D5F-87D8-EA09A0F0A0FF

Q36260908-A394E464-CB7F-4C8A-8F24-83313467573B

Q36260908-D758CA8F-A599-4DB1-B906-AE2F8A71BA8B

P932

Q36260908-E3F546F0-7EF4-4BE3-B120-42F6B3E01BF8

P356

S10194-009-0170-Y

P1433

The journal of headache and pain : official journal of the Italian Society for the Study of Headaches

P1476

Does sumatriptan cross the blood-brain barrier in animals and man?

@en

P2860

Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice

Nitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptan

CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges

Characterization of the human 5-hydroxytryptamine1B receptor.

Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan.

Effects of sumatriptan on nitric oxide and superoxide balance during glyceryl trinitrate infusion in the rat. Implications for antimigraine mechanisms.

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy.

Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

P2888

s10194-009-0170-y

P304

5-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10194-009-0170-Y

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Peer Carsten Tfelt-Hansen

P577

2009-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40689559

http://www.w3.org/2001/XMLSchema#string

P698

20012125

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

blood–brain barrier

mechanism of action

P932

3452191

http://www.w3.org/2001/XMLSchema#string